Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812110 · ClinicalTrials.gov registry record · Phase 4
Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
A Phase 4 study, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 336
- Enrollment target
NCT00812110: Completed Phase 4 study, sponsored by Akron Children's Hospital.
NCT00812110 is a Phase 4 study that has completed, run by Akron Children's Hospital. The registered enrollment target is 336 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00812110, a Phase 4 study, has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 336 participants
- Enrollment target
Study Summary
We hypothesize that when offered influenza vaccine at little or no cost, in a setting where the value of the vaccine is connected to one's high risk child, vaccination rates for parents will approach 90-95%, similar to rates obtained in the Neonatal Intensive Care Unit environment.
Primary Outcome
Caregivers identified for participation were offered influenza vaccine. This describes the number who accepted vaccination
Interventions
- DRUG Influenzae vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
What the finished NCT00812110 record still lists
NCT00812110 is an interventional study that assigns participants to a tested intervention. The registered 336 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 1 intervention - of which Influenzae vaccine is the first listed.
NCT00812110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00812110 about?
NCT00812110 is a clinical study titled "Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home". We hypothesize that when offered influenza vaccine at little or no cost, in a setting where the value of the vaccine is connected to one's high risk child, vaccination rates for parents will approach 90-95%, similar to rates obtained in the Neonatal Intensive Care Unit environment.
What is the current status of trial NCT00812110?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 336 participants. The study started on 2008-12. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00812110?
The interventions under investigation include: Influenzae vaccine (DRUG).
Who is sponsoring clinical trial NCT00812110?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00812110's enrollment target sits among peer trials
336 250th of 2000 higher than 1,750 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- NCT03977207 · 336 participants · NA
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- NCT04665206 · 336 participants · Phase 1
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- NCT05124457 · 336 participants · Phase 2
DETERMINE: Detemir vs NPH
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia